BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37187315)

  • 1. The pathophysiological role of dihydroceramide desaturase in the nervous system.
    Tzou FY; Hornemann T; Yeh JY; Huang SY
    Prog Lipid Res; 2023 Jul; 91():101236. PubMed ID: 37187315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophagy prevents activity-dependent neurodegeneration due to dihydroceramide accumulation
    Jung WH; Liu CC; Yu YL; Chang YC; Lien WY; Chao HC; Huang SY; Kuo CH; Ho HC; Chan CC
    EMBO Rep; 2017 Jul; 18(7):1150-1165. PubMed ID: 28507162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of dihydrosphingolipids in disease.
    Magaye RR; Savira F; Hua Y; Kelly DJ; Reid C; Flynn B; Liew D; Wang BH
    Cell Mol Life Sci; 2019 Mar; 76(6):1107-1134. PubMed ID: 30523364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy.
    Pant DC; Dorboz I; Schluter A; Fourcade S; Launay N; Joya J; Aguilera-Albesa S; Yoldi ME; Casasnovas C; Willis MJ; Ruiz M; Ville D; Lesca G; Siquier-Pernet K; Desguerre I; Yan H; Wang J; Burmeister M; Brady L; Tarnopolsky M; Cornet C; Rubbini D; Terriente J; James KN; Musaev D; Zaki MS; Patterson MC; Lanpher BC; Klee EW; Pinto E Vairo F; Wohler E; Sobreira NLM; Cohen JS; Maroofian R; Galehdari H; Mazaheri N; Shariati G; Colleaux L; Rodriguez D; Gleeson JG; Pujades C; Fatemi A; Boespflug-Tanguy O; Pujol A
    J Clin Invest; 2019 Mar; 129(3):1240-1256. PubMed ID: 30620337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The atypical sphingolipid SPB 18:1(14Z);O2 is a biomarker for DEGS1 related hypomyelinating leukodystrophy.
    Hülsmeier AJ; Toelle SP; Bellstedt P; Wentzel C; Bahr A; Kolokotronis K; Hornemann T
    J Lipid Res; 2023 Dec; 64(12):100464. PubMed ID: 37890668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.
    Fabrias G; Muñoz-Olaya J; Cingolani F; Signorelli P; Casas J; Gagliostro V; Ghidoni R
    Prog Lipid Res; 2012 Apr; 51(2):82-94. PubMed ID: 22200621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEGS1 -related leukodystrophy: a clinical report and review of literature.
    Wong MST; Thomas T; Lim JY; Kam S; Teo JX; Ching J; Goh CYJ; Jamuar SS; Lim WK; Koh AL
    Clin Dysmorphol; 2023 Jul; 32(3):106-111. PubMed ID: 37195341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of function and reduced levels of sphingolipid desaturase DEGS1 variants are both relevant in disease mechanism.
    Dei Cas M; Montavoci L; Pasini C; Caretti A; Penati S; Martinelli C; Gianelli U; Casati S; Nardecchia F; Torella A; Brunetti-Pierri N; Trinchera M
    J Lipid Res; 2024 Mar; 65(3):100517. PubMed ID: 38342436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology.
    Casasampere M; Ordoñez YF; Pou A; Casas J
    Chem Phys Lipids; 2016 May; 197():33-44. PubMed ID: 26248324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity.
    Rodriguez-Cuenca S; Barbarroja N; Vidal-Puig A
    Biochim Biophys Acta; 2015 Jan; 1851(1):40-50. PubMed ID: 25283058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for quantifying hepatic and intestinal ceramides on mice by UPLC-MS/MS.
    Ge K; Zheng D; Wang J; Jia W; Zhao A
    Anal Biochem; 2023 Jan; 661():114982. PubMed ID: 36375519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells.
    Zhu Y; Cho K; Lacin H; Zhu Y; DiPaola JT; Wilson BA; Patti GJ; Skeath JB
    bioRxiv; 2024 May; ():. PubMed ID: 38260379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroceramide desaturase regulates the compartmentalization of Rac1 for neuronal oxidative stress.
    Tzou FY; Su TY; Lin WS; Kuo HC; Yu YL; Yeh YH; Liu CC; Kuo CH; Huang SY; Chan CC
    Cell Rep; 2021 Apr; 35(2):108972. PubMed ID: 33852856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroceramide biology. Structure-specific metabolism and intracellular localization.
    Kok JW; Nikolova-Karakashian M; Klappe K; Alexander C; Merrill AH
    J Biol Chem; 1997 Aug; 272(34):21128-36. PubMed ID: 9261117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
    Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity.
    Planas-Serra L; Launay N; Goicoechea L; Heron B; Jou C; Juliá-Palacios N; Ruiz M; Fourcade S; Casasnovas C; De La Torre C; Gelot A; Marsal M; Loza-Alvarez P; García-Cazorla À; Fatemi A; Ferrer I; Portero-Otin M; Area-Gómez E; Pujol A
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36951944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydroceramide desaturase promotes the formation of intraluminal vesicles and inhibits autophagy to increase exosome production.
    Wu CY; Jhang JG; Lin WS; Chuang PH; Lin CW; Chu LA; Chiang AS; Ho HC; Chan CC; Huang SY
    iScience; 2021 Dec; 24(12):103437. PubMed ID: 34877496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection.
    Hayashi Y; Matsuda K; Tanigawa K; Tanikawa T; Maeda K; Tsuchiya K
    Biol Pharm Bull; 2022; 45(10):1559-1563. PubMed ID: 36184516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the trans double bond in skin barrier sphingolipids: permeability and infrared spectroscopic study of model ceramide and dihydroceramide membranes.
    Skolová B; Jandovská K; Pullmannová P; Tesař O; Roh J; Hrabálek A; Vávrová K
    Langmuir; 2014 May; 30(19):5527-35. PubMed ID: 24779554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
    Jang Y; Rao X; Jiang Q
    J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.